Advertisement

Topics

Global Bio based Polyethylene Teraphthalate PET Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 2022 Prices from USD $5900

23:28 EST 3 Mar 2017 | BioPortfolio Reports

The global bio based polyethylene teraphthalate PET market is growing at the CAGR of 29.9% and will contribute $73900 billion till 2022.The global bio based polyethylene teraphthalate PET market is sub segmented into applications and regional outlook. In application segment, market is divided into bottles, packaging, fibers, automotive, injection molding and others. Bottle and packaging segment dominates the application segment. The major rise in application of bio based PET is due to its lightweight and durable characteristic. PET is used as exterior as well as interior components of their automobiles which is expected to propel the biobased PET application market growth over the forecast year. Nissan, Toyota and ATT have announced to use biobased product in their vehicles which is expected to have positive effect on the growth of biobased PET market. Other applications of the product include consumer goods packaging and carrier bags.

In regional outlook, market is divided into North America, Asia Pacific, Europe and Rest of the World. Asia Pacific dominates the global bio based polyethylene Teraphthalate PET Market having around 35% of market shares, this dominance is expected to be in forecast year. India, China and Japan are the major countries in Asia Pacific region. Japanese government started an initiative related to green plastics; Japanese government has projected to target the consumption of around 20% of bio plastics by 2020. North America and European region have stringent rules and regulations towards standard PET usage, as it is harmful for the environment, which is boosting up the global bio based polyethylene teraphthalate PET market in these regions.

Rising crude oil prices is expected to boost the global biobased polyethylene terephthalate PET market growth over the forecast year. Biobased polyethylene teraphthalate is manufactured from bio based products such as bacteria, regenerated cellulose, cornstarch and other organic products. Presently, biobased polyethylene teraphthalate contains around 35% biocontent. Major players are investing heavily to investigate the feasibility for 100% renewable content biobased polyethylene teraphthalate, and it is expected to create greater opportunities for the market participants. The CocaCola Company and Torray industries have formed partnership with Virent and Anellotech to develop bio polyethylene teraphthalate. This is anticipated to fuel biobased polyethylene teraphthalate market growth over the next five years. The development is also expected to solve the polyethylene teraphthalate supply problem for many manufacturing industries to meet their demand. Crude oil reserves depletion and overgrowing petroleum prices is projected to shift the synthetic polyethylene teraphthalate based industries towards the biobased polyethylene teraphthalate. Tremendous growth of packaging material market is anticipated to have positive influence on biobased polyethylene teraphthalate market growth in the forecast period.

Some of the major market players are the Coca Cola company, Natureworks, Indorama Ventures, Novamont S.P.A, Metabolix Inc., Ianan Biologics materials, Tiajjin green biomaterials, Evonik industries, RTP Company, Techno polymer Co. Ltd., Toray industries Inc., etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

Original Article: Global Bio based Polyethylene Teraphthalate PET Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 2022 Prices from USD $5900

NEXT ARTICLE

More From BioPortfolio on "Global Bio based Polyethylene Teraphthalate PET Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 2022 Prices from USD $5900"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...